Biosimilars: Affordable and Effective Alternatives to Biologics
Biosimilars are biologic medical products that are highly similar to an already approved reference biologic drug. They are designed to […]
Biologics
Stay informed on the latest in biologic medicines with Biologics Insights. Explore trends, research updates, regulatory news, and innovations in therapeutic biologics, biosimilars, and advanced biologic treatments.
Hong Kong: New Drugs, Generics, Biosimilars Regulations
Hong Kong- New Drugs, Generics, Biosimilar Regulations: Hong Kong has a robust regulatory system for pharmaceuticals, overseen by the Department
Biologics and Biosimilars Regulations, Registration Process in the USA (FDA)
The size of the U.S. biosimilars market, estimated at USD 6.73 billion in 2021, is expected to increase by USD
New Drugs, Generics and Biosimilars Registration in Singapore: Whitepaper on HSA Regulations
Singapore stands as a beacon of regulatory excellence in the pharmaceutical industry, offering a robust framework that ensures the safety,
Biologics and Biosimilars Regulations and Registration in Brazil
According to the Drugs Sector Regulation Chamber (CMED) in 2022, the Brazilian pharmaceutical sector generated US $17.2 billion in sales
Biologics and Biosimilars Regulations and Registration in Australia (TGA)
The Australian healthcare system has transformed with the availability of biologic and biosimilar medications. The market for Australian biosimilars, which
Biologics and Biosimilars Regulations and Registration in Mexico (COFEPRIS)
Mexico is the second-largest drug market in Latin America, after Brazil. With a compound annual growth rate (CAGR) of 38.7%,